Marilyn C. Darkes

1.2k total citations
18 papers, 1.0k citations indexed

About

Marilyn C. Darkes is a scholar working on Immunology, Materials Chemistry and Oncology. According to data from OpenAlex, Marilyn C. Darkes has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 6 papers in Materials Chemistry and 5 papers in Oncology. Recurrent topics in Marilyn C. Darkes's work include Nitric Oxide and Endothelin Effects (5 papers), HIV Research and Treatment (4 papers) and Chemokine receptors and signaling (4 papers). Marilyn C. Darkes is often cited by papers focused on Nitric Oxide and Endothelin Effects (5 papers), HIV Research and Treatment (4 papers) and Chemokine receptors and signaling (4 papers). Marilyn C. Darkes collaborates with scholars based in United States, Belgium and Canada. Marilyn C. Darkes's co-authors include Simon P. Fricker, Michael J. Abrams, Katsuichi Ohtsuki, Holden T. Maecker, Susan Kopiwoda, Francis G. Blankenberg, Jonathan F. Tait, Peter D. Katsikis, Robert C. Robbins and R. Eric Davis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemical and Biophysical Research Communications.

In The Last Decade

Marilyn C. Darkes

18 papers receiving 973 citations

Peers

Countries citing papers authored by Marilyn C. Darkes

Since Specialization

Citations

This map shows the geographic impact of Marilyn C. Darkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn C. Darkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn C. Darkes more than expected).

Fields of papers citing papers by Marilyn C. Darkes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn C. Darkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn C. Darkes. The network helps show where Marilyn C. Darkes may publish in the future.

Co-authorship network of co-authors of Marilyn C. Darkes

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn C. Darkes. A scholar is included among the top collaborators of Marilyn C. Darkes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn C. Darkes. Marilyn C. Darkes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Prospective CCR5 Small Molecule Antagonist Compound Design Using a Combined Mutagenesis/Modeling Approach 2011 ·Journal of the American Chemical Society ·Markus Metz, (unknown), Jean Labrecque, Sanjay Danthi, Jonathan Langille, Curtis Harwig, Wen Yang, Marilyn C. Darkes, Gloria Lau, (unknown), Gary Bridger, Dominique Schols, Simon P. Fricker, Renato T. Skerlj	12
2	Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication 2011 ·Bioorganic & Medicinal Chemistry Letters ·Renato T. Skerlj, Gary Bridger, Yuanxi Zhou, (unknown), Jonathan Langille, (unknown), (unknown), Wen Yang, Tong‐Shuang Li, Letian Wang, (unknown), Ian R. Baird, Markus Metz, Marilyn C. Darkes, Jean Labrecque, Gloria Lau, Simon P. Fricker, Dana Huskens, Dominique Schols	2
3	HIV-1 entry inhibition by small-molecule CCR5 antagonists: A combined molecular modeling and mutant study using a high-throughput assay 2011 ·Virology ·Jean Labrecque, Markus Metz, Gloria Lau, Marilyn C. Darkes, Rebecca S.Y. Wong, (unknown), (unknown), Gang Chen, Tong‐Shuang Li, (unknown), Dominique Schols, Gary Bridger, Simon P. Fricker, Renato T. Skerlj	21
4	The molecular pharmacology of AMD11070: An orally bioavailable CXCR4 HIV entry inhibitor 2011 ·Biochemical Pharmacology ·Renée Mosi, (unknown), Jennifer H. Cox, Marilyn C. Darkes, (unknown), Jean Labrecque, Gloria Lau, Kim L. Nelson, Ketan Patel, (unknown), Rebecca S.Y. Wong, Renato T. Skerlj, Gary Bridger, Dana Huskens, Dominique Schols, Simon P. Fricker	42
5	Pharmacology of AMD3465: A small molecule antagonist of the chemokine receptor CXCR4 2009 ·Biochemical Pharmacology ·V. Bodart, (unknown), Marilyn C. Darkes, (unknown), Jean Labrecque, Gloria Lau, Renée Mosi, (unknown), Kim L. Nelson, Melanie C. Ruzek, Ketan Patel, (unknown), Robert J. Scarborough, Rebecca S.Y. Wong, Gary Bridger, Ron MacFarland, Simon P. Fricker	48
6	Characterization of the molecular pharmacology of AMD3100: A specific antagonist of the G-protein coupled chemokine receptor, CXCR4 2006 ·Biochemical Pharmacology ·Simon P. Fricker, (unknown), Jennifer H. Cox, Marilyn C. Darkes, Ognjen Grujic, (unknown), Jean Labrecque, Gloria Lau, Renée Mosi, Kim L. Nelson, Ling Qin, (unknown), Rebecca S.Y. Wong	174
7	The Development of an Europium-GTP Assay to Quantitate Chemokine Antagonist Interactions for CXCR4 and CCR5 2005 ·Assay and Drug Development Technologies ·Jean Labrecque, (unknown), Gloria Lau, Marilyn C. Darkes, Renée Mosi, Simon P. Fricker	14
8	Ru^III Complexes of Edta and Dtpa Polyaminocarboxylate Analogues and Their Use as Nitric Oxide Scavengers 2005 ·European Journal of Inorganic Chemistry ·Tim Storr, Beth R. Cameron, Robert A. Gossage, Helen S. Yee, Renato T. Skerlj, Marilyn C. Darkes, Simon P. Fricker, Gary Bridger, Nathan Davies, Michael T. Wilson, Kevin Maresca, Jon Zubieta	20
9	Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger 2003 ·Journal of Thoracic and Cardiovascular Surgery ·Irvin Mayers, Thomas S. Hurst, Anna Radomski, David H. Johnson, Simon P. Fricker, Gary Bridger, Beth R. Cameron, Marilyn C. Darkes, Marek W. Radomski	19
10	Ruthenium(III) Polyaminocarboxylate Complexes: Efficient and Effective Nitric Oxide Scavengers 2003 ·Inorganic Chemistry ·Beth R. Cameron, Marilyn C. Darkes, Helen S. Yee, (unknown), Simon P. Fricker, Renato T. Skerlj, Gary Bridger, Nathan Davies, Michael T. Wilson, David J. Rose, Jon Zubieta	48
11	Ruthenium(III) Triazacyclononane Dithiocarbamate, Pyridinecarboxylate, or Aminocarboxylate Complexes as Scavengers of Nitric Oxide 2003 ·Inorganic Chemistry ·Beth R. Cameron, Marilyn C. Darkes, Ian R. Baird, Renato T. Skerlj, (unknown), Simon P. Fricker	37
12	Mechanistic Studies on AMD6221: A Ruthenium-Based Nitric Oxide Scavenger 2002 ·Biochemical and Biophysical Research Communications ·Renée Mosi, Béatrice Séguin, Beth R. Cameron, (unknown), Marilyn C. Darkes, Simon P. Fricker	28
13	A Ruthenium (III) Polyaminocarboxylate Complex, A Novel Nitric Oxide Scavenger, Enhances Graft Survival and Decreases Nitrosylated Heme Protein in Models of Acute and Delayed Cardiac Transplant Rejection 2002 ·Journal of Cardiovascular Pharmacology ·Galen M. Pieper, Allan M. Roza, Mark B. Adams, Gail Hilton, Mary Johnson, Christopher C. Felix, Bal Kampalath, Marilyn C. Darkes, (unknown), Beth R. Cameron, Simon P. Fricker	29
14	In vivo detection and imaging of phosphatidylserine expression during programmed cell death 1998 ·Proceedings of the National Academy of Sciences ·Francis G. Blankenberg, Peter D. Katsikis, Jonathan F. Tait, R. Eric Davis, (unknown), Katsuichi Ohtsuki, Susan Kopiwoda, Michael J. Abrams, Marilyn C. Darkes, Robert C. Robbins, Holden T. Maecker, H. William Strausś	440
15	The synthesis and in vitro photodynamic activity of a series of novel ruthenium(II)-2,3-naphthalocyanines 1997 ·Journal of Photochemistry and Photobiology B Biology ·Jean F. Vollano, Gerald E. Bossard, Stephen A. Martellucci, Marilyn C. Darkes, Michael J. Abrams, Robert C. Brooks	12
16	Pharmacokinetics of Polyoxometalates after Multiple‐dose Administration in Rats 1996 ·Pharmacy and Pharmacology Communications ·Lan Ni, Geoffrey Henson, Marilyn C. Darkes, Gerald E. Bossard, F. Douglas Boudinot	4
17	Convenient Synthesis of Water Soluble, Isomerically Pure Ruthenium Phthalocyanine Complexes 1995 ·Inorganic Chemistry ·Gerald E. Bossard, Michael J. Abrams, Marilyn C. Darkes, Jean F. Vollano, Robert C. Brooks	34
18	Pharmacokinetics of antiviral polyoxometalates in rats 1994 ·Antimicrobial Agents and Chemotherapy ·Lan Ni, F. Douglas Boudinot, (unknown), (unknown), Gerald E. Bossard, Stephen A. Martellucci, (unknown), Simon P. Fricker, Marilyn C. Darkes, (unknown)	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact